The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa

被引:0
|
作者
Hanagasi, HA [1 ]
Kaptanoglu, G [1 ]
Sahin, HA [1 ]
Emre, M [1 ]
机构
[1] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Behav Neurol & Movement Disorders Unit, TR-34390 Istanbul, Turkey
关键词
D O I
10.1002/1531-8257(200009)15:5<1016::AID-MDS1042>3.0.CO;2-J
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1016 / 1017
页数:2
相关论文
共 48 条
  • [31] THE USE OF THE SPECIFIC L-DOPA TEST FOR STUDYING THE SYMPATHOADRENAL SYSTEM IN PATIENTS OF DIFFERENT AGES SUFFERING FROM MITRAL VALVULAR DISEASE
    DANILOV, AA
    KISELEVA, ZM
    GRIGORYANTS, RA
    MUKHARLYAMOV, NM
    TERAPEVTICHESKII ARKHIV, 1990, 62 (11) : 98 - 102
  • [32] Chemical evaluation of Mucuna species for L-dopa content - an anti-Parkinson's drug yielding medicinal plant from India
    Raina, Archana P.
    Misra, R. C.
    INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE, 2018, 17 (01): : 148 - 154
  • [33] RP-HPLC Analysis of Anti-Parkinson’s Drug l-DOPA Content in Mucuna Species from Indian Subcontinent
    Patil R.
    Aware C.
    Gaikwad S.
    Rajebhosale M.
    Bapat V.
    Yadav S.
    Jadhav J.
    Proceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2019, 89 (4) : 1413 - 1420
  • [34] The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities
    Mingote, Laia Ruiz
    Namutamba, Dorothy
    Apina, Francis
    Barnabas, Nomampondo
    Contreras, Carmen
    Elnour, Taharqa
    Frick, Mike Watson
    Lee, Cynthia
    Seaworth, Barbara
    Shelly, Debra
    Skipper, Natalie
    dos Santos Filho, Ezio Tavora
    LANCET, 2015, 385 (9966): : 477 - 479
  • [35] Genomic Characterization of Drug-Resistant Mycobacterium tuberculosis L2/Beijing Isolates from Astana, Kazakhstan
    Auganova, Dana
    Atavliyeva, Sabina
    Amirgazin, Asylulan
    Akisheva, Akmaral
    Tsepke, Anna
    Tarlykov, Pavel
    ANTIBIOTICS-BASEL, 2023, 12 (10):
  • [36] The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease
    Nash, JE
    Ravenscroft, P
    McGuire, S
    Crossman, AR
    Menniti, FS
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 2004, 188 (02) : 471 - 479
  • [37] l-Dopa release from mesoporous silica nanoparticles engineered through the concept of drug-structure-directing agents for Parkinson's disease
    Morales, V
    McConnell, J.
    Perez-Garnes, M.
    Almendro, N.
    Sanz, R.
    Garcia-Munoz, R. A.
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (20) : 4178 - 4189
  • [39] Chemical Profiling, Antioxidant, and Antimicrobial Activity against Drug-Resistant Microbes of Essential Oil from Withania frutescens L.
    El Moussaoui, Abdelfattah
    Bourhia, Mohammed
    Jawhari, Fatima Zahra
    Salamatullah, Ahmad Mohammad
    Ullah, Riaz
    Bari, Ahmed
    Majid Mahmood, Hafiz
    Sohaib, Muhammad
    Serhii, Bohza
    Rozhenko, Alexander
    Aboul-Soud, Mourad A. M.
    Ezzeldin, Essam
    Mostafa, Gamal A. E.
    Bousta, Dalila
    Bari, Amina
    APPLIED SCIENCES-BASEL, 2021, 11 (11):
  • [40] Chemical Analysis and Antioxidant and Antimicrobial Activity of Essential oils from Artemisia negrei L. against Drug-Resistant Microbes
    Chebbac, Khalid
    El Moussaoui, Abdelfattah
    Bourhia, Mohammed
    Salamatullah, Ahmad Mohammad
    Alzahrani, Abdulhakeem
    Guemmouh, Raja
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021